Lebenthal Global Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Sell
22,760
-1,909
-8% -$310K 0.49% 41
2025
Q4
$4.81M Buy
24,669
+8,030
+48% +$1.91M 0.74% 25
2025
Q3
$4.68M Buy
16,639
+152
+0.9% +$38.7K 0.82% 23
2025
Q2
$3.6M Buy
16,487
+963
+6% +$156K 0.67% 26
2025
Q1
$2.17M Buy
15,524
+5,742
+59% +$935K 0.41% 33
2024
Q4
$1.63M Buy
9,782
+828
+9% +$147K 0.3% 52
2024
Q3
$1.53M Buy
8,954
+120
+1% +$17.4K 0.31% 45
2024
Q2
$1.25M Buy
+8,834
New +$1.1M 0.27% 47
2021
Q1
Sell
-200
Closed -$12K 413
2020
Q4
$12K Buy
+200
New +$11.9K 0.01% 427

Other funds holding ORCL

Lebenthal Global Advisors's ORCL Position: Q1 2026 in Review

Lebenthal Global Advisors reduced its Oracle (ORCL) stake by 7.7% in Q1 2026, selling an estimated $310K and leaving 22,760 shares worth $3.35M. The position accounts for 0.49% of the portfolio, ranked #41.

Lebenthal Global Advisors first reported a position in ORCL in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.81M in Q4 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Lebenthal Global Advisors held 22,760 shares of Oracle worth $3.35M as of Q1 2026.
  • Lebenthal Global Advisors sold 1,909 Oracle shares in Q1 2026, an estimated $310K.
  • Oracle made up 0.49% of Lebenthal Global Advisors's portfolio in Q1 2026, its #41 holding.
  • Lebenthal Global Advisors first reported a position in Oracle in Q4 2020 and has held it in 9 quarters since.
  • Lebenthal Global Advisors's Oracle position peaked at $4.81M in Q4 2025.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.